MRVI (MRVI) revenue breakdown

· Market cap $2.7B

By segment, TriLink is the largest at 64% of fiscal 2025 revenue, growing 9% a year over 6 years.

By region, North America is the largest at 61% of fiscal 2025 revenue; Asia Pacific grew fastest, 10% a year over 6 years.

Revenue by segment

Fiscal years, as MRVI reports them in its 10-K filings; fiscal 2025 total $186M.

Segments2019202020212022202320242025Share
TriLink$73M$208M$712M$813M$225M$196M$120M 64%
Cygnus$44M$55M$68M$70M$64M$63M$66M 36%
Protein Detection$26M$23M————— —
Protein Detection——$19M———— —

Revenue by region

Fiscal years, as MRVI reports them in its 10-K filings; fiscal 2025 total $186M.

Regions2019202020212022202320242025Share
North America$84M$150M$317M$339M$141M$127M$112M 61%
Asia Pacific$24M$43M$84M$110M$97M$89M$41M 22%
Europe, the Middle East and Africa$35M$90M$398M$433M$50M$42M$31M 17%
Latin and Central America$642,000$474,000$842,000$808,000$527,000$662,000$971,000 1%
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for MRVI.
Open MRVI in Investingly

Questions

Where does MRVI make its money?

In fiscal 2025, by segment: TriLink $120M, Cygnus $66M.

From MRVI's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.